Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study 2015-03-19 cgbio 조회수Views : 1,433 Kong M, Hong SE. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study. Asian Pacific journal of cancer prevention : APJCP 2013; 14(8): 4859-64 다음글Epidermal growth factor and epidermal growth factor signaling attenuate laser-induced melanogenesis 이전글The combined use of recombinant human epidermal growth factor (rh-EGF, Nepidermin) and fractional carbon dioxide laser in reducing cutaneous scar formation